| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Dec'16 | Sep'16 | Jun'16 | Mar'16 | Sep'15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total revenue | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | 0 | 0 | - | - | - | - | - | - |
License and collaboration revenue | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 0 | - | - | - | - | - |
Total revenue | |||||||||||||||||
5,009 | 4,896 | 7,553 | 6,885 | 6,433 | 5,991 | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - |
Operating expenses: | |||||||||||||||||
Research and development | |||||||||||||||||
25,261 | 25,172 | 24,451 | 21,550 | 21,537 | 23,045 | 24,319 | 23,815 | 24,601 | 25,212 | 28,229 | 38,024 | 45,530 | 46,489 | 40,538 | 0 | 0 | 0 |
General and administrative | |||||||||||||||||
9,925 | 10,412 | 11,307 | 12,312 | 11,621 | 11,507 | 11,254 | 10,721 | 11,462 | 13,113 | 14,664 | 14,395 | 14,501 | 13,337 | 11,776 | 0 | 0 | 0 |
Total operating expenses | |||||||||||||||||
35,186 | 35,584 | 35,758 | 33,862 | 33,158 | 34,552 | 35,573 | 34,536 | 36,063 | 38,325 | 42,893 | 52,419 | 60,031 | 59,826 | 52,314 | 0 | 0 | 0 |
Operating loss | |||||||||||||||||
-30,177 | -30,688 | -28,205 | -26,977 | -26,725 | -28,561 | -32,880 | -31,624 | -33,083 | -35,679 | -40,985 | -51,378 | -59,707 | -59,826 | -52,314 | 0 | 0 | 0 |
Other income, net: | |||||||||||||||||
Interest income | |||||||||||||||||
184 | 177 | 204 | 234 | 281 | 297 | 251 | 190 | 104 | 87 | 0 | 0 | 0 | - | - | - | - | - |
Interest expense | |||||||||||||||||
- | 2 | 263 | 525 | 785 | 1,047 | 1,047 | 1,047 | 1,048 | 1,048 | 0 | 0 | 0 | - | - | - | - | - |
Change in fair value of warrant liability | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | 0 | - | - | - | - | - | - | - |
Other income, net | |||||||||||||||||
88 | 136 | 155 | 160 | 128 | 72 | 45 | 18 | 14 | 19 | 0 | 0 | 0 | - | - | - | - | 0 |
Total other income, net | |||||||||||||||||
270 | 311 | 96 | -131 | -376 | -678 | -751 | -839 | -930 | -942 | -625 | -379 | -115 | 127 | 0 | 0 | 0 | - |
Loss from continuing operations | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
Loss from discontinued operations | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
Net Income (Loss) Attributable to Parent | |||||||||||||||||
-29,907 | -30,377 | -28,109 | -27,108 | -27,101 | -29,239 | -33,631 | -32,463 | -34,013 | -36,621 | -41,610 | -51,757 | -59,822 | -59,699 | -52,714 | 0 | 0 | 0 |
Comprehensive loss | |||||||||||||||||
-29,907 | -30,377 | -28,109 | -27,108 | -27,101 | -29,239 | -32,886 | 0 | 0 | - | 0 | - | - | - | - | - | - | - |
Continuing operations | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.45 |
Discontinued operations | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.21 |
Net loss per share, basic and diluted (in USD per share) | |||||||||||||||||
-0.17 | -0.22 | -0.36 | -0.32 | -0.25 | -0.14 | -0.33 | -0.32 | -0.35 | -0.50 | -0.46 | -0.62 | -0.71 | 7.70 | -5.76 | -7.31 | -4.60 | -2.66 |
Weighted-average common shares outstanding, basic and diluted (in shares) | |||||||||||||||||
37,043 | 26,685 | 26,189 | 26,069 | 26,066 | 26,056 | 26,046 | 26,039 | 25,026 | 15,997 | 15,984 | 15,975 | 15,967 | 16,015 | 3,033 | 2,448 | 2,445 | 2,281 |
License and collaboration revenue | |||||||||||||||||
Total revenue | |||||||||||||||||
4,401 | 4,477 | 7,337 | 6,885 | 6,433 | 5,982 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - |
Research and development services revenue | |||||||||||||||||
Total revenue | |||||||||||||||||
- | - | - | - | - | 9 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - |
Government research contracts and grants revenue | |||||||||||||||||
Total revenue | |||||||||||||||||
608 | 419 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - |